Certara Inc. Company Profile
NASDAQ: CERTTechnologyComputer Software: Prepackaged SoftwareUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Certara at a glance
Certara Inc. (NASDAQ: CERT) is a Computer Software: Prepackaged Software company in the Technology sector headquartered in Radnor, PA. Certara is led by Mr. Jon Resnick and employs about 1,515 people. The company's shares have traded publicly since 2020.
At a market capitalization of $1.63 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001827090, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Certara do?
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- Certara Inc.
- Ticker
- NASDAQ: CERT
- Sector
- Technology
- Industry
- Computer Software: Prepackaged Software
- CEO
- Mr. Jon Resnick
- Employees
- 1,515
- Headquarters
- 4 Radnor Corporate Center, Radnor, PA, United States
- Phone
- 415 237 8272
- Website
- certara.com
- IPO year
- 2020
- Market cap
- $1.63B
- SEC CIK
- 0001827090
- Latest annual report
- 10-K · Feb 26, 2026
Companies similar to Certara
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRGSProgress Software Corporation | 39.94 | -2.39% | $1.63B | vs CERT |
| KCKingsoft Cloud Holdings Limited ADR | 5.47 | -8.38% | $1.64B | vs CERT |
| MQMarqeta Inc. Class A | 16.24 | -1.16% | $1.69B | vs CERT |
| CXMSprinklr Inc. Class A | 6.55 | +0.46% | $1.52B | vs CERT |
| CNXCConcentrix Corporation | 29.26 | +2.45% | $1.79B | vs CERT |
| AIC3.ai Inc. Class A | 9.13 | -9.06% | $1.47B | vs CERT |
| NYAXNayax Ltd. | 47.01 | -4.16% | $1.79B | vs CERT |
| KAROKarooooo Ltd. | 59.45 | -2.03% | $1.84B | vs CERT |